PUNCTUR-GUARD®: Proven needle stick injury prevention technology -- MEDICA - World Forum for Medicine


CardioMed Supplies Inc.

PUNCTUR-GUARD®: Proven needle stick injury prevention technology

CardioMed, an ISO 13485:2003-certified medical device manufacturer, has developed and won approvals for Punctur-Guard, a uniquely designed and engineered disposable safety product line for blood sampling and intravenous infusions. The long-established Canadian company will reintroduce Punctur-Guard at MEDICA 2012, the world’s largest annual medical exhibition, in Düsseldorf, Germany, November 14 – 17. Punctur-Guard’s unique passive, self-blunting technology protects medical professionals against contaminated needle sticks, a serious occupational hazard.

“Contaminated needle stick injuries (NSIs) can be life-threatening to clinicians, affecting them physically, mentally and socio-economically. The sticks usually occur within two seconds after the needle is removed from the patient’s skin and the needle is still bare,” explains Raphael Dubé, CardioMed’s vice president of sales and marketing. “But unlike other so-called safety needle products, the Punctur-Guard’s self-blunting protective mechanism is activated while the needle is still inside the patient, covering and blunting the needle tip the instant it is withdrawn – so the two-minute window of danger when a needle is traditionally lying bare, is no more.”

Punctur-Guard provides improved patient comfort and superior safety, completely preventing NSIs. CardioMed product lines including Blood Collection Needles, Winged Infusion Sets, and Drop-IT Needle Holders all come with Punctur-Guard self-blunting technology.

A landmark study conducted throughout France by GERES and published in Infection Control and Hospital Epidemiology (April 2010, Vol, 31, No 4), compared needle stick safety devices and concluded that automatic safety (passive) devices perform 2 -3 times better than manually activated protective, sliding, or toppling devices. Purpose of the study was to evaluate the incidence of NSIs caused by different safety engineered devices (SEDs) used in healthcare settings.

Another positive for using passive devices: Punctur-Guard requires less training. That, in turn, achieves greater compliance and safer procedures compared to manually activated safety devices, which staff often bypass or refuse to use because of their inherent risks.

At MEDICA this year, CardioMed will be looking to appoint distributors for Punctur-Guard and its wide range of other specialized health care products, which have all won CE mark, Health Canada, and FDA approval and can be sold internationally.

CardioMed is looking forward to meeting you at MEDICA. So please visit us and enjoy our hospitality at the Ontario, Canada Pavilion in Hall 16, booth G42.

In the meantime, for more information contact:
Raphael Dubé
VP Sales & Marketing


Jamal Mustafa
Export Manager

Also, please visit our www.cardiomed.com website and look us up on the MEDICA www.medica.de website.